Advertisement
| biological response modifier therapy: Biological Response Modifiers and Cancer Therapy J. W. Chiao, 1988 |
| biological response modifier therapy: Biological Response Modifiers National Cancer Institute (U.S.) Subcommittee on Biological Response Modifiers, 1983 |
| biological response modifier therapy: Combination Therapies E. Garaci, Allan L Goldstein, 1992-04-01 |
| biological response modifier therapy: Rationale of Biological Response Modifiers in Cancer Treatment Eiro Tsubura, Tadao Aoki, Ichirō Urushizaki, 1985 |
| biological response modifier therapy: Biological Response Modifiers Paul Torrence, 2012-12-02 Biological Response Modifiers: New Approaches to Disease Intervention focuses on biological response modifiers (BRMs) and the ways they provide novel approaches to disease control. It examines how BRMs act through an organism's own biological response mechanisms and how their mechanisms of action can be utilized to develop new modalities of chemotherapy. Organized into 15 chapters, this volume begins with an overview of specific agents and approaches to biological therapy, the basic concepts of immunity, and BRM screening. It then discusses interferons and their immunoregulatory functions; mechanism of interferon action; how nucleic acids and polynucleotides regulate the immune system; clinical applications of thymosins and other thymic hormones; the antibacterial and antineoplastic properties of tuftsin; and production and characterization of tumor necrosis factor. The reader is also introduced to detection and activity of colony-stimulating factor; the role of neuroendocrine hormones in the immune system; chalones and other endogenous inhibitors of cell proliferation; biochemistry of lymphotoxins; muramyl peptides as immunopharmacological response modifiers; biological activities of transfer factor in leukocyte dialysates; and requirements for activation and growth of human lymphocytes. This book is a valuable resource for immunologists, clinicians, biochemists, and organic/medicinal chemists. |
| biological response modifier therapy: Combination Therapies 2 E. Garaci, Allan L. Goldstein, 2012-10-24 The 2nd International Symposium on Combination Therapies brought together several hundred of the leading researchers, scientists and clinicians in this area to discuss new and emerging uses for biological response modifiers (BRM's) in the treatment of cancer and infectious diseases. The meeting was held during May 1-3, 1992 in Acireale, Sicily (Italy). It was hosted by Professor G. Nicoletti CU. of Catania) and organized by the Institute for Advanced Studies in Immunology and Aging (Washington, D. C. ) in collaboration with the University of Rome Tor Vergata, the University of Catania and The George Washington University Medical Center. The synergy exhibited between BRM's and conventional therapies including bone marrow and other lymphoid cell transplants is a rapidly expanding area with significant promise for the treatment of human diseases. Advances in this area of biomedicine are leading to the rapid development of new therapeutic approaches that are being applied clinically as both primary and adjuvant therapy to enhance the effectiveness of conventional treatments. The 2nd International Symposium on Combination Therapy provided a setting for the exchange of new scientific information regarding the emerging uses for BRM's alone or in combination with conventional therapies. The 1st International Symposium on Combination Therapies was held in 1991 in Washington, D. C. |
| biological response modifier therapy: Biological Response Modifiers — Interferons, Double-Stranded RNA and 2′,5′-Oligoadenylates W.E.G. Müller, H.C. Schröder, 2012-12-06 Biological response modifiers are increasingly used in viral and cancer therapy. Since alterations of the immune system are the primary symptoms of HIV infection, especially therapies directed towards the modulation of the immune response have been under intense evaluation. This volume summarizes current knowledge of the interferon-based natural antiviral protection system including 2',5'-oligoadenylate and double-stranded RNA. It will also help to develop further a solid scientific rationale for the practical use of heterologous immunomodulators in the clinics. |
| biological response modifier therapy: Cancer Biotherapy Annie Young, Lewis Rowett, David Kerr, 2006-05-04 Recent advances in biology and immunology have led to major developments in cancer therapies. Biotherapy, based on stimulating the immune system to attack cancer cells, is currently entering clinical practice. This book combines discussion of the underlying principles with strong clinical focus, highlighting clinical relevance and treatment issues. |
| biological response modifier therapy: Biotherapy Paula Trahan Rieger, 2001 Rieger (U. of Texas M.D. Anderson Cancer Center) synthesizes knowledge about this rapidly expanding field to help other nurses understand its biological basis and clinical indications. Targeted at oncology nurses, the text will also be of interest in other specialties using biological agents to trea |
| biological response modifier therapy: Biological Response Modifiers in Human Oncology and Immunology Andor Szentivanyi, 2013-11-11 The topic of biological response modifiers has attracted the attention of many biomedical investigators, including immunologists, oncologists, pharmacologists, microbiologists, and biochemists, as well as clinical practitioners of medicine. This has occurred mainly because of the realization that the complex system of cellular and humoral interactions culminating in a productive immune response is under exquisite regulatory control for normal immune responses and that loss of control may markedly influence the capability of a host to respond in a productive manner to the numerous immunologic insults encountered in the environment. Furthermore, biological response modification is considered by many to be a natural offshoot of the relatively new application of immunotherapy to cancer. It is widely recognized that immunotherapy was practiced at the end of the last century and the beginning of this century when it was recognized that microbial infections were caused by distinct species of bacteria and that passive administration of serum con taining antibody to these microbes or their products could, in many cases, favorably influence the outcome of an infectious process. |
| biological response modifier therapy: Developing a Protocol for Observational Comparative Effectiveness Research: A User's Guide Agency for Health Care Research and Quality (U.S.), 2013-02-21 This User’s Guide is a resource for investigators and stakeholders who develop and review observational comparative effectiveness research protocols. It explains how to (1) identify key considerations and best practices for research design; (2) build a protocol based on these standards and best practices; and (3) judge the adequacy and completeness of a protocol. Eleven chapters cover all aspects of research design, including: developing study objectives, defining and refining study questions, addressing the heterogeneity of treatment effect, characterizing exposure, selecting a comparator, defining and measuring outcomes, and identifying optimal data sources. Checklists of guidance and key considerations for protocols are provided at the end of each chapter. The User’s Guide was created by researchers affiliated with AHRQ’s Effective Health Care Program, particularly those who participated in AHRQ’s DEcIDE (Developing Evidence to Inform Decisions About Effectiveness) program. Chapters were subject to multiple internal and external independent reviews. More more information, please consult the Agency website: www.effectivehealthcare.ahrq.gov) |
| biological response modifier therapy: Safety of Biologics Therapy Brian A. Baldo, 2016-08-12 This long overdue title provides a comprehensive, up-to-date, state-of-the art review of approved biologic therapies, with coverage of mechanisms of action, Indications for therapy, immunogenicity and a detailed examination of adverse effects and safety of the many and diverse therapeutic agents presented in a total of 13 chapters. It is predicted that by 2016, biologics will make up half of the world's 20 top-selling drugs and by 2018, biologic medicine sales will account for almost half of the world's 100 biggest selling drugs. Recombinant proteins dominate the growing list of the more than 200 approved biotherapeutic agents with targeted antibodies, fusion proteins and receptors; cytokines; hormones; enzymes; proteins involved in blood-clotting, homeostasis and thrombosis; vaccines; botulinum neurotoxins; and, more recently, biosimilar preparations, comprising the majority of approved biologics. Written with clinicians, other health care professionals, and researchers in mind, Safety of Biologics Therapy examines, in a single volume, the full range of issues surrounding the safety of approved biologic therapies. A good understanding of the risks and safety issues of modern biologics therapy is increasingly being demanded of all those connected with their development, handling, prescribing, administration and subsequent patient management. In addition to being of great value to clinicians in all branches of medicine, and to nurses, pharmacists and researchers, this book will prove invaluable for students taking undergraduate and graduate courses in the above disciplines and in the biomedical sciences. |
| biological response modifier therapy: Ciottone's Disaster Medicine Gregory R. Ciottone, Paul D Biddinger, Robert G. Darling, Saleh Fares, Mark E Keim, Michael S Molloy, Selim Suner, 2015-11-05 The most comprehensive resource of its kind, Ciottone's Disaster Medicine, 2nd Edition, thoroughly covers isolated domestic events as well as global disasters and humanitarian crises. Dr. Gregory Ciottone and more than 200 worldwide authorities share their knowledge and expertise on the preparation, assessment, and management of both natural and man-made disasters, including terrorist attacks and the threat of biological warfare. Part 1 offers an A-to-Z resource for every aspect of disaster medicine and management, while Part 2 features an exhaustive compilation of every conceivable disaster event, organized to facilitate quick reference in a real-time setting. Quickly grasp key concepts, including identification of risks, organizational preparedness, equipment planning, disaster education and training, and more advanced concepts such as disaster risk reduction, tactical EMS, hazard vulnerability analysis, impact of disaster on children, and more. Understand the chemical and biologic weapons known to exist today, as well as how to best manage possible future events and scenarios for which there is no precedent. Be prepared for man-made disasters with new sections that include Topics Unique to Terrorist Events and High-Threat Disaster Response and Operational Medicine (covering tactical and military medicine). Get a concise overview of lessons learned by the responders to recent disasters such as the earthquake in Haiti, Hurricane Sandy, the 2014 Ebola outbreak, and active shooter events like Sandy Hook, CT and Aurora, CO. Learn about the latest technologies such as the use of social media in disaster response and mobile disaster applications. Ensure that everyone on your team is up-to-date with timely topics, thanks to new chapters on disaster nursing, crisis leadership, medical simulation in disaster preparedness, disaster and climate change, and the role of non-governmental agencies (NGOs) in disaster response - a critical topic for those responding to humanitarian needs overseas. Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices. |
| biological response modifier therapy: Cumulated Index Medicus , 1994 |
| biological response modifier therapy: 2008 Oncology Nursing Drug Handbook Gail M. Wilkes, Margaret Barton-Burke, 2007-12 2008 Oncology Nursing Drug Handbook is a comprehensive nursing resource for assessment, intervention, and patient education in the administration of oncology drugs. This text reviews drug information |
| biological response modifier therapy: Biological Response Modifiers in the Treatment of Hematopoietic Neoplasia Moshe Talpaz, Razelle Kurzrock, Jordan U. Gutterman, 1992 |
| biological response modifier therapy: National Cancer Institute Monograph , 1983 |
| biological response modifier therapy: Biological Response Modifiers Paul F. Torrence, 1985 Biological Response Modifiers: New Approaches to Disease Intervention focuses on biological response modifiers (BRMs) and the ways they provide novel approaches to disease control. It examines how BRMs act through an organism's own biological response mechanisms and how their mechanisms of action can be utilized to develop new modalities of chemotherapy. Organized into 15 chapters, this volume begins with an overview of specific agents and approaches to biological therapy, the basic concepts of immunity, and BRM screening. It then discusses interferons and their immunoregulatory functions; mec ... |
| biological response modifier therapy: Cancer Mortality in the United States, 1950-1977 Frank W. McKay, Margot R. Hanson, 1982 |
| biological response modifier therapy: New Directions in Cancer Treatment Ian T. Magrath, 2012-12-06 During the last few decades, there has been a tremendous improvement in the treatment of cancer. There is evidence that this trend is continuing, based on the achievements re sulting from the combined efforts of clinicians and basic re search workers. This book is an example of such interaction and collaboration. It was prepared by authors representing both areas of work. Most of the work reported in this book is not merely theoretical, but has been experimentally successfully tested and sometimes applied clinically. This work has, however, not yet been generalized and practiced on a wide scale. Some of the results reported here relate to new aspects and open new horizons for future progress. This book will be of great value for both clinicians and basic research workers. VICC Treatment and Rehabilitation Programme ISMAIL ELSEBAI Chairman Preface The three main approaches to the treatment of cancer are surgery, radiotherapy, and chemotherapy. Today, all malignant neoplasms are managed by one or more of these modalities, with varying success rates depending on the type of tumor, its degree of spread, and the knowl edge and skill with which the treatment plan has been designed and executed. In the United States of America and in Europe, approximate ly half of all cancer is presently curable, but this has been the case for approximately 20 years. |
| biological response modifier therapy: Biomedical Index to PHS-supported Research , 1990 |
| biological response modifier therapy: Immunology Guidebook Julius Cruse, Robert Lewis, Huan Wang, 2004-08-05 The Immunology Guidebook provides an easily accessible text-reference to the more up-to-date and difficult concepts in the complex science of immunology. It aims to demystify basic concepts and specialised molecular and cellular interactions. Its 18 chapters offer a logical and sequential presentation where much of the data is displayed in carefully designed tables. This book is intended for immunology students, researchers, practitioners and basic biomedical scientists. - Tables provide a quick reference to 'difficult to find' immunology data - A distillate of the latest information on immunogenetics of the human MHC associated with tissue transplantation - Information boxes featurw related web resources |
| biological response modifier therapy: The Chemotherapy Source Book Michael Clinton Perry, 2008 The Chemotherapy Source Book, Fourth Edition pulls together all the current information on the chemotherapeutic management of cancer patients, including choice of chemotherapeutic agents, use of combinations, and toxicity of individual drugs. Organized by disease site, the book brings together pharmacologic and patient management information in one source that clinicians can consult for any question encountered in the delivery of chemotherapy. This updated Fourth Edition includes new drugs as well as new indications for older drugs. Content has been streamlined to provide essential information more quickly for the busy practitioner. Plus, this edition is softcover for greater portability and convenience. |
| biological response modifier therapy: Harnessing Medicinal Plants in Cancer Prevention and Treatment Roy, Arpita, 2024-03-11 In a world grappling with the relentless impact of cancer, claiming nearly 10 million lives in 2020 alone, the pursuit of effective prevention and treatment methods is more crucial than ever. Harnessing Medicinal Plants in Cancer Prevention and Treatment delves into promising medicinal plants, exploring their potential in the prevention and treatment of various types of cancer. Acknowledging the limitations and risks associated with synthetic medicines, the book emphasizes the significance of traditional medicine, revealing that approximately 80% of the global population relies on plant-based remedies for primary health care. Within these pages, readers will find a comprehensive exploration of diverse medicinal plants and their active compounds, unraveling their mode of action against cancer. The content spans continents, from the phytochemical and biological properties of anticancer medicinal plants in India to the role of Chinese and Thai plants in cancer prevention and treatment. Each chapter meticulously examines specific plants or compounds, such as the renowned Curcuma longa, or the intriguing Momordica charantia, providing an in-depth analysis of their anticancer properties. This book elucidates the multifaceted role of plant-derived compounds in various cancer types, addressing their efficacy and safety profiles. The book is rich with insights into the potential of bioactive compounds to serve as lead candidates in drug discovery, highlighting the importance of plants in developing effective anticancer agents. This book is an invaluable resource for a diverse audience, including biotechnologists, plant biologists, pharmacologists, and cancer-related researchers. |
| biological response modifier therapy: The Encyclopedia of Hepatitis and Other Liver Diseases James H. Chow, Cheryl Chow, 2006 Hepatitis is an inflammation of the liver brought on by viral infections, autoimmune diseases, alcohol abuse, exposure to toxins, or other causes. |
| biological response modifier therapy: Encyclopedia of Medical Immunology Ian R. Mackay, Noel R. Rose, 2019 Offering a broad appeal to microbiologists, immunologists, and infectious disease specialists, this four volume encyclopedia covers all autoimmune, tropical, and infectious diseases. Emphasis will also be placed on genetics, physiology, metabolism, pathogenesis and applied microbiology. Under the leadership of some of the most world renowned names in the field, the encyclopedia will bring together an outstanding collection of contributions by top scientists in a variety of fields. Volumes 1-3: Diseases will be divided by the 11 main sections of the body, namely Integumentary, Skeletal, Respiratory, Digestive, Urinary, and Reproductive. For some of the autoimmune disease, more then one system will be involved but the delineation serves to broadly break down the diseases into systems. Volume 4 will cover the vaccines for said diseases and future prospects will be offered by leaders in industry and academia. Volume 4 will also be broken down into all the body systems, as in the other two volumes. For each vaccine, for each disease, and in each system the following will be included: • A list of the vaccines currently available along with a list of the companies that manufacture them • Molecular Immunology of the Vaccine • Type of Immunity involved in protection • Mode of Vaccination for each vaccine; repeated boosters and length of immunological memory • Commercial production of vaccines • Storage of vaccines • Standardization and Control of Vaccines • WHO programs and World-Wide Disease Eradication Programs based upon Vaccines. |
| biological response modifier therapy: The Encyclopedia of Women's Reproductive Cancer Carol Turkington, Mitchell Edelson, 2005 Presents articles on female reproductive cancer, including symptoms, current research, and treatment options. Includes resource directories. |
| biological response modifier therapy: Advances in Immunopharmacology J. Hadden, L. Chedid, P. Mullen, 2016-04-19 Advances in Immunopharmacology documents the proceedings of the First International Conference on Immunopharmacology held in Brighton, England, in July 1980. The volume contains 60 papers organized into 10 parts. The papers in Part I examine the pharmacology of immunotherapeutic drugs and immunotoxicology. Part II presents studies on thymic hormones. Part III is devoted to immunopharmacologic approaches to diseases other than cancer. Part IV deals with mechanisms of chemotaxis degranulation and microbicidal action. Part V focuses on cancer immunopharmacology and immunotherapy while Part VI covers the mechanisms of inflammatory and allergic processes. Part VII takes up the immune testing of the actions of immunotherapeutic agents. Part VIII discusses prostaglandins and macrophage suppression. Part IX is devoted to selected topics such as mechanism of action of soluble immune response suppressor and new approaches to the therapy of allergic diseases. Part X presents discussions during the therapy communication sessions. |
| biological response modifier therapy: Cancer Treatment Reports , 1987 |
| biological response modifier therapy: Watson's Clinical Nursing and Related Sciences E-Book Mike Walsh, Alison Crumbie, 2007-07-25 Previous editions of this popular textbook have provided nursing students with the comprehensive guide they need to a wide range of clinical nursing issues. This edition continues to provide this comprehensive support, but also reflects the changing context of nursing care in the 21st century. It reflects the growing importance of primary health and the community, the move towards evidence-based practice and the importance of the multi-disciplinary team. The text is designed to emphasise the importance of holistic, patient-focussed nursing. It addresses health assessment and introduces students to key aspects of the medical history and physical exam. Contemporary issues such as substance misuse are also examined.Clearly written and well-organised to support study, the text also features case studies, critical incidents and care plans. The chapters include extensive 2-colour artwork and are supported by current references and suggestions for further reading. Electronic ancillary material is available at http://evolve.elsevier.com/Walsh/Watsons/ Comprehensive, nursing focussed textbook Emphasis on holistic nursing care rather than bio-medical approach Includes material on all major client groups including children, older people, and mental health clients. Reflects hospital and community aspects of nursing care for major disorders Case studies and care plans included Well-designed in two colours and easy to use Each `disorder' chapter features key themes of psychological and social dimensions of care; involving family; discharge planning; requirements for care after discharge; nursing care within the context of the multi-disciplinary team; evidence-based practice • Supplementary electronic ancillaries on Evolve: narrated Powerpoint presentations and related case studies.• A new chapter on non-medical prescribing and principles of safe practice. • An updated edition of the Watson’s Clinical nursing pocket book prepared specifically for this edition to be published in the same year |
| biological response modifier therapy: Principles and Practice of Pediatric Infectious Diseases E-Book Sarah S. Long, Charles G. Prober, Marc Fischer, David Kimberlin, 2022-03-10 Comprehensive in scope, yet concise and easy to manage, Principles and Practice of Pediatric Infectious Diseases, 6th Edition, by Drs. Sarah S. Long, Charles G. Prober, Marc Fischer, and new editor David Kimberlin, is your go-to resource for authoritative information on infectious diseases in children and adolescents. A veritable who's who of global authorities provides the practical knowledge you need to understand, diagnose, and manage almost any pediatric infectious disease you may encounter. - Covers the latest aspects of the COVID-19 pandemic, including manifestations, diagnosis, management, and prevention of SARS-CoV-2 infection. - Features an easy-access format with high-yield information boxes, highlighted key points, and an abundance of detailed illustrations and at-a-glance tables. - Allows quick look-up by clinical presentation, pathogen, or type of host. - Highlights expanding antimicrobial resistance patterns and new therapies for viral and fungal infections and resistant bacterial infections. - Includes coverage of the latest vaccine products, recommendations, and effectiveness. - Reviews emerging healthcare-associated infections, their management, control, and prevention. - Contains a new chapter on Chorioamnionitis and Neonatal Consequences. |
| biological response modifier therapy: Cancer Management in Man Paul V. Woolley, 2012-12-06 This volume, the last in this series on cancer growth and Moreover, the current status of plant-derived vinca alka progression, is a companion volume to Volume IX and loids and non-alkaloid natural products is summarized. further explores established and novel approaches for the Advances in hyperthermia and additional approaches for therapy of patients with malignant neoplasms. The stra the therapy of malignancies are also presented. tegies reflected in these volumes are direct extrapolations The volume continues with chapters on bone marrow from the basic science of cancer biology, growth and pro transplantation as well as hematologic and nutritional sup gression described in earlier volumes of this series. Some port for the cancer patient. Blood pressure in the cancer approaches are directed towards the eradication or modifi patient, therapy for nausea and vomiting as well as pain are cation of the properties of heterogeneous malignant tumor discussed. The last chapter is devoted to the problems of the cells at various stages of tumor progression, while other terminally ill, including evaluations of the burden relatives approaches are directed towards modification of the host and friends of the cancer patient have to bear. antitumor defense systems, e. g. , enhancement of host anti It is clear that important advances in the basic science of tumor immune reactivity. |
| biological response modifier therapy: Meeting of the President's Cancer Panel United States. President's Cancer Panel, 1986 |
| biological response modifier therapy: Cancer Sourcebook, 9th Ed. James Chambers, 2021-10-01 Consumer health information about risks, prevention, and treatment of major forms of cancer. Includes index, glossary of related terms, and other resources. |
| biological response modifier therapy: Medical-Surgical Nursing - E-Book Donna D. Ignatavicius, M. Linda Workman, Cherie Rebar, 2017-09-09 Awarded second place in the 2018 AJN Book of the Year Awards in Medical-Surgical Nursing! Healthcare is evolving at an incredible pace and with it, the roles and responsibilities of the medical-surgical nurse. Ensure you are fully equipped to thrive and adapt in this ever-changing nursing environment with Ignatavicius, Workman, and Rebar's Medical-Surgical Nursing: Concepts for Interprofessional Collaborative Care, 9th Edition. This trendsetting text not only covers all essential adult health knowledge, but also reinforces the application, conceptual thinking, and clinical judgment skills that today’s nurses need to stay one step ahead in delivering exceptional patient care, no matter the environment. As with previous Iggy editions, you’ll find a unique collaborative care approach to adult health nursing, a thorough integration of QSEN competencies, extensive NCLEX® Exam preparation, and a direct, reader-friendly tone throughout the text. This ninth edition incorporates two emerging and complementary trends — the Core Competencies for Interprofessional Collaborative Practice and a more conceptual approach teaching and learning — areas that will ground you in how to think like a nurse and how to apply the knowledge you gain from the text to clinical practice. There are a lot of med-surg nursing texts out there, but there’s only one that combines all the information, concepts, and on-the-job realities in a way that makes perfect sense: Iggy! Trendsetting QSEN integration emphasizes patient safety and evidence-based practice with Nursing Safety Priority boxes, including Drug Alerts, Critical Rescues, and Action Alerts. UNIQUE! Emphasis on clinical judgment helps you develop skills in clinical reasoning and clinical decision-making when applying concepts to clinical situations. Strong emphasis on NCLEX Exam preparation includes chapter-opening Learning Outcomes and chapter-ending Get Ready for the NCLEX Examination! sections organized by NCLEX Client Needs Categories, plus NCLEX Examination Challenge questions, with an answer key in the back of the book and on the Evolve companion website. Exceptionally readable content features shorter sentences, straightforward vocabulary, and a direct, reader-friendly writing style. |
| biological response modifier therapy: 2009 Oncology Nursing Drug Handbook Gail M. Wilkes, Margaret Barton Burke, 2008-12-05 Written Expressly For Nurses Caring For Patients With Cancer, The 2009 Oncology Nursing Drug Handbook Uniquely Expresses Drug Therapy In Terms Of The Nursing Process: Nursing Diagnoses, Etiologies Of Toxicities, And Key Points For Nursing Assessment, Intervention, And Evaluation. An Essential Reference Updated Annually, The Text Provides Valuable Information On Effective Symptom Management, Patient Education, And Chemotherapy Administration. Completely Revised And Updated, The 2009 Oncology Nursing Drug Handbook Includes: - New, Administered Drugs: Amrubicin, Patupilone; Levoleucovorin, Dexrazoxane For Injection (Extravasation), Casopitant, Fosaprepitant, Granisetron Hcl Transdermal, Desvenlafaxine, Denosumab, Methlnaltrexone Bromide - Drug Updates For Bendamustine And Ixapapilone - Specific Drugs Are Described In Terms Of Their Mechanism Of Action, Metabolism, Drug Interactions, Laboratory Effects/Interference, And Special Considerations. The Most Important And Common Drug Side Effects Are Also Discussed. |
| biological response modifier therapy: 2005 Oncology Nursing Drug Handbook Gail M. Wilkes, 2004-12 This essential reference provides valuable information on effective symptom management and chemotherapy administration. The only oncology drug book that is updated every year. |
| biological response modifier therapy: Research Awards Index , 1985 |
| biological response modifier therapy: 2006 Oncology Nursing Drug Handbook Gail M. Wilkes, Margaret Barton-Burke, 2006 2006 Oncology Nursing Drug Handbook is a comprehensive nursing resource for assessment, intervention, and patient education in the administration of oncology drugs. This text reviews drug information from the nurse's point of view, and helps the nurse focus on minimizing toxicity. This essential reference provides valuable information on effective symptom management and chemotherapy administration for the oncology nurse. Updated annually, the 2006 edition includes the following new drugs: four antineoplastic agents (clofarabine, histrelin implant, paclitaxel protein bound particles for injection, TLK 286), four antimicrobial agents (micafungin, rifaximin, gemifloxacin, tigecycline), two immunotherapy/biotherapy symptom management agents (Imiquimod 5% cream., palifermin), and eight molecularly targeted drugs (lapatanib, panitumumab, pertuzumab, sorafeni (BAY 43-9006), sunitinib malate (sutent, SU11246), temsirolimus, tipifarnib, vatalanib), and one symptom management drug (ziconotide intrathecal infusion). In addition, indications and additional toxicity data have been updated for individual drugs, such as bevacizumab, cetuximab, and gefitinib. |
| biological response modifier therapy: Lewis's Medical-Surgical Nursing Diane Brown, Helen Edwards, Lesley Seaton, Thomas Buckley, 2017-03-25 Perfect for: • Undergraduate Nursing Students • Postgraduate Specialist Nursing Pathways (Advanced Medical Surgical Nursing) • TAFE Bachelor of Nursing Program Lewis’s Medical–Surgical Nursing: Assessment and Management of Clinical Problems, 4th Edition is the most comprehensive go-to reference for essential information about all aspects of professional nursing care of patients. Using the nursing process as a framework for practice, the fourth edition has been extensively revised to reflect the rapid changing nature of nursing practice and the increasing focus on key nursing care priorities. Building on the strengths of the third Australian and New Zealand edition and incorporating relevant global nursing research and practice from the prominent US title Medical–Surgical Nursing, 9Th Edition, Lewis’s Medical–Surgical Nursing, 4th Edition is an essential resource for students seeking to understand the role of the professional nurse in the contemporary health environment. 49 expert contributors from Australia and New Zealand Current research data and Australian and New Zealand statistics Focus on evidence-based practice Review questions and clinical reasoning exercises Evolve Resources for instructor and student, including quick quiz’s, test banks, review questions, image gallery and videos. • Chapter on current national patient safety and clinical reasoning • Over 80 new and revised case studies • Chapter on rural and remote area nursing • Fully revised chapter on chronic illness and complex care • Chapter on patient safety and clinical reasoning • Greater emphasis on contemporary health issues, such as obesity and emergency and disaster nursing • Australia and New Zealand sociocultural focus |
International Day for Biological Diversity: Harmony between …
May 19, 2025 · This year’s International Day for Biological Diversity, on Thursday, 22 May 2025, highlights the inherent connections between people and the natural world through the theme, …
Biologicals - World Health Organization (WHO)
Jan 12, 2025 · Biologicals are a class of medicines made from living cells taken from plants, animals or bacteria. These cells are use in creating many types of health care products, …
TRS 1060 - Annex 6: Guideline on bioanalytical method validation …
Apr 15, 2025 · This guideline is intended to provide recommendations for the validation of bioanalytical methods for chemical and biological drug quantification in biological matrices and …
Laboratory biosafety manual, 4th edition - World Health …
Dec 21, 2020 · This fourth edition of the manual builds on the risk assessment framework introduced in the third edition. A thorough, evidence-based and transparent assessment of the …
Immunization, Vaccines and Biologicals - World Health …
The Immunization, Vaccines and Biologicals department is responsible for targeting vaccine-preventable diseases, guiding immunization research and establishing immunization policy.
Biological weapons - World Health Organization (WHO)
Sep 6, 2018 · Biological weapons form a subset of a larger class of weapons sometimes referred to as unconventional weapons or weapons of mass destruction, which also includes chemical, …
Determinants of health
Oct 4, 2024 · Food and water are the major sources of exposure to both chemical and biological hazards. They impose a substantial health risk to consumers and economic burdens on …
Biotherapeutic products - World Health Organization (WHO)
A major industrial application of biotechnology is in the development and preparation of biological medicinal products using genetically engineered bacteria, yeast, fungi, cells or even whole …
Ionizing radiation and health effects
Jul 27, 2023 · WHO fact sheet on ionizing radiation, health effects and protective measures: includes key facts, definition, sources, type of exposure, health effects, nuclear emergencies, …
Mental health
Jun 17, 2022 · Individual psychological and biological factors such as emotional skills, substance use and genetics can make people more vulnerable to mental health problems. Exposure to …
International Day for Biological Diversity: Harmony between …
May 19, 2025 · This year’s International Day for Biological Diversity, on Thursday, 22 May 2025, highlights the inherent connections between people and the natural world through the theme, …
Biologicals - World Health Organization (WHO)
Jan 12, 2025 · Biologicals are a class of medicines made from living cells taken from plants, animals or bacteria. These cells are use in creating many types of health care products, …
TRS 1060 - Annex 6: Guideline on bioanalytical method validation …
Apr 15, 2025 · This guideline is intended to provide recommendations for the validation of bioanalytical methods for chemical and biological drug quantification in biological matrices and …
Laboratory biosafety manual, 4th edition - World Health …
Dec 21, 2020 · This fourth edition of the manual builds on the risk assessment framework introduced in the third edition. A thorough, evidence-based and transparent assessment of the …
Immunization, Vaccines and Biologicals - World Health …
The Immunization, Vaccines and Biologicals department is responsible for targeting vaccine-preventable diseases, guiding immunization research and establishing immunization policy.
Biological weapons - World Health Organization (WHO)
Sep 6, 2018 · Biological weapons form a subset of a larger class of weapons sometimes referred to as unconventional weapons or weapons of mass destruction, which also includes chemical, …
Determinants of health
Oct 4, 2024 · Food and water are the major sources of exposure to both chemical and biological hazards. They impose a substantial health risk to consumers and economic burdens on …
Biotherapeutic products - World Health Organization (WHO)
A major industrial application of biotechnology is in the development and preparation of biological medicinal products using genetically engineered bacteria, yeast, fungi, cells or even whole …
Ionizing radiation and health effects
Jul 27, 2023 · WHO fact sheet on ionizing radiation, health effects and protective measures: includes key facts, definition, sources, type of exposure, health effects, nuclear emergencies, …
Mental health
Jun 17, 2022 · Individual psychological and biological factors such as emotional skills, substance use and genetics can make people more vulnerable to mental health problems. Exposure to …
